Invivyd issues 6.8M-share warrant to Population Health Partners under $3M consulting deal

Invivyd, Inc.

Cash fee of $500,000/month for 6 months ($3M aggregate) for clinical development advisory services.
Warrant for up to 6,824,712 shares at $3.48/share; vests in tranches tied to market cap milestones up to $1.5B by 2030.
Invivyd board members Clive Meanwell and Tamsin Berry are respectively managing partner and partner of PHP.
PHP to advise on clinical development and regulatory matters for NVD200 and other candidates.
Press release highlights PHP leadership team’s success at The Medicines Company and Pfizer.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Invivyd, Inc. entered into Master Services Agreement with Population Health Partners, L.P. valued at aggregate fee of $3,000,000 (effective 2022-11-15).

Action: entry
Counterparty: Population Health Partners, L.P.
Value: aggregate fee of $3,000,000
Effective: 2022-11-15

Exact text from the filing

On November 15, 2022 (the “Effective Date”), Invivyd, Inc. (the “Company”) entered into a Master Services Agreement with Population Health Partners, L.P. (“PHP”), pursuant to which PHP agreed to provide services and create deliverables for the Company as agreed between the Company and PHP and set forth in one or more work orders under such agreement (the “MSA”).

View on SEC.gov

Browse all material agreements →

Invivyd, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-22-287208

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.